Navigation Links
Volcano Corporation Presentation at Roth Capital Conference to be Webcast
Date:3/10/2011

SAN DIEGO, March 10, 2011 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the Roth 23rd Annual Orange County Growth Stock Conference on Monday, March 14.

The presentation by David Sheehan, President, IVUS and FM Business Units, will begin at 11:30 a.m., Pacific Daylight Time, (2:30 p.m., Eastern Daylight Time).

The presentation will be available through the conference website at http://www.wsw.com/webcast/roth24/volc/ and via the company's website at www.volcanocorp.com.

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.


'/>"/>
SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki
2. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
3. Volcano Announces Positive Clinical Experience With Its Second Generation OCT Catheter, Prepares for U.S. Regulatory Study
4. Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
5. Volcano Corporation Schedules First Quarter Conference Call, Webcast
6. Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast
7. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
8. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
9. Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
10. Volcano Corporation Schedules First Quarter Conference Call, Webcast
11. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... G. Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering and Computer ... Research Award winner. Presented annually, the award recognizes an individual who has ...
(Date:7/20/2017)... ... , ... VIC Technology Venture Development™ (VIC™), is pleased to announce ... addition continues to strengthen and diversify VIC’s board. , "We are excited to have ... highly accomplished business executive with a broad range of experience directly relevant to VIC ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):